SORARU', GIANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.928
EU - Europa 1.477
AS - Asia 1.123
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 13.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.912
CN - Cina 543
IT - Italia 491
SG - Singapore 425
FI - Finlandia 236
SE - Svezia 203
DE - Germania 119
GB - Regno Unito 112
UA - Ucraina 110
FR - Francia 100
VN - Vietnam 92
HK - Hong Kong 28
RU - Federazione Russa 28
IN - India 19
NL - Olanda 18
IE - Irlanda 16
CA - Canada 15
RO - Romania 7
CH - Svizzera 6
BG - Bulgaria 5
ES - Italia 5
HU - Ungheria 4
ID - Indonesia 4
TR - Turchia 4
BR - Brasile 3
EU - Europa 3
GR - Grecia 3
AT - Austria 2
BE - Belgio 2
CZ - Repubblica Ceca 2
IL - Israele 2
KR - Corea 2
NO - Norvegia 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
DK - Danimarca 1
EG - Egitto 1
IR - Iran 1
KZ - Kazakistan 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 13.538
Salva come PNG Salva come JPEG
Città #
Fairfield 1.757
Woodbridge 1.298
Houston 1.144
Ann Arbor 907
Ashburn 805
Seattle 717
Wilmington 617
Chandler 608
Cambridge 587
Singapore 335
Jacksonville 316
Boardman 227
San Diego 180
Princeton 176
Padova 171
Santa Clara 146
Beijing 133
Medford 112
Des Moines 98
Roxbury 96
Dong Ket 92
Helsinki 89
Nanjing 84
Milan 45
New York 34
Norwalk 27
Shenyang 27
Hong Kong 25
Guangzhou 23
Detroit 21
Hebei 21
London 21
Washington 20
Lappeenranta 19
Dallas 18
Munich 18
Dublin 16
Jinan 16
Kharkiv 16
Nanchang 16
Dearborn 15
Jiaxing 13
Treviso 12
Los Angeles 11
Phoenix 11
Tianjin 11
Changsha 10
Ogden 10
Redwood City 10
Shanghai 10
Zhengzhou 10
Auburn Hills 9
Brescia 9
Hefei 9
Kunming 9
Paris 9
Verona 9
Venice 8
Borås 7
Martellago 7
Rome 7
Chicago 6
Florence 6
Ovada 6
Prescot 6
Timisoara 6
Chiswick 5
Espoo 5
Indiana 5
Sofia 5
St Louis 5
Tappahannock 5
Trento 5
Zurich 5
Atlanta 4
Hangzhou 4
Kilburn 4
Ningbo 4
Rockville 4
Taiyuan 4
Toronto 4
Aprilia 3
Bologna 3
Buffalo 3
Chengdu 3
Cumming 3
Düsseldorf 3
Eastleigh 3
Falls Church 3
Frankfurt am Main 3
Fuzhou 3
Genoa 3
Madrid 3
Montegrosso d'Asti 3
Montréal 3
Palazzolo sull'Oglio 3
Palermo 3
Redmond 3
Southwark 3
São Paulo 3
Totale 11.439
Salva come PNG Salva come JPEG
Nome #
Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy’s Disease) 492
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 197
Specific numerical processing impairment in ALS patients 186
null 171
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 171
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet 170
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 162
Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients. 157
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 157
Parkinson-like features in ALS with predominant upper motor neuron involvement 152
Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study. 151
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. 150
210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands 148
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 141
Progress in enzyme replacement therapy in glycogen storage disease type II 140
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 140
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 135
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 135
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 135
Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers 135
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 132
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 130
Abnormal free radical homeostasis and oxphos activity in ALS muscle 129
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 127
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population. 125
C9ORF72 repeat expansion in a large Italian ALS cohort: Evidence of a founder effect 125
New FIG4 gene mutations causing aggressive ALS 124
Theory of mind, empathy and neuropsychological functioning in X-linked Spinal and Bulbar Muscular Atrophy: a controlled study of 20 patients 121
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 120
Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis 118
Muscle MRI and functional outcome measures in Becker muscular dystrophy 117
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients 115
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. 114
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 114
Epidemiology of ALS in Padova district, Italy, from 1992 to 2005 111
Enhanced neural empathic responses in patients with Spino-Bulbar Muscular Atrophy: An electrophysiological study 110
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. 108
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations 108
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 107
The MITOS system predicts long-term survival in amyotrophic lateral sclerosis 106
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia 105
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 105
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 105
Mitochondrial implications in bulbospinal muscular atrophy (Kennedy disease) 104
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 104
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 103
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 102
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 102
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 101
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 101
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 101
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 101
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease 100
Quality of life and motor impairment in ALS: Italian validation of ALSAQ 99
Efficacy of Hypnosis-Based Treatment in Amyotrophic Lateral Sclerosis: A Pilot Study 99
Impact on children of a parent with ALS: a case-control study 99
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 98
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1 98
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 97
Memory deficits and retrieval processes in ALS 97
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 97
Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease 96
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. 96
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 95
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 95
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 94
Lithium carbonate in amyotrophic lateral sclerosis Lack of efficacy in a dose-finding trial 94
Skeletal muscle satellite cells in amyotrophic lateral sclerosis 94
Genetic variation in KIFAP3 is associated with an upper motor neuron-predominant phenotype in amyotrophic lateral sclerosis 93
Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients 92
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. 92
The clinical spectrum of CASQ1-related myopathy 92
Factors predicting survival in ALS: a multicenter Italian study 91
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 90
Spinal and bulbar muscular atrophy: Skeletal muscle pathology in male patients and heterozygous females. 89
Clinical and electrophysiological correlations in a three-generation-HNPP pedigree. 88
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 88
Correlation of quality of life and motor impairment in amyotrophic lateral sclerosis 87
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 87
Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis 87
Diagnostica e prevenzione delle malattie neuromuscolari 86
Unilateral calf hypertrophy due to S1-radiculopathy 86
Cardiac function in types II and III spinal muscular atrophy: Should we change standards of care? 86
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 84
Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations 83
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study 83
Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers 83
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 82
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 80
A severe case of Duchenne-like muscular dystrophy due to a mutation in the alpha-sarcoglycan (adhalin) gene 79
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 79
Natural history of upper motor neuron-dominant ALS 78
Towards a European Registry and Biorepository for Patients with Spinal and Bulbar Muscular Atrophy 78
Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients 76
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 76
A pilot trial with clenbuterol in amiotrophic lateral sclerosis (ALS) 76
Evaluation of peripherin in biofluids of patients with motor neuron diseases 75
Natural history of upper motor neuron-dominant ALS 74
Emotional Lability in MND: Relationship to cognition and psychopathology and impact on caregivers. 73
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 73
Totale 11.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.523
article - articoli 41.352
book - libri 111
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 172
Totale 88.158
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.272 0 0 0 0 0 0 270 263 265 226 138 110
2020/20212.630 74 144 80 745 122 190 100 172 291 289 245 178
2021/20222.097 156 235 316 146 65 111 167 182 53 46 227 393
2022/20231.454 284 104 15 170 254 183 2 141 186 18 77 20
2023/2024838 20 96 100 65 68 104 54 61 28 35 99 108
2024/20251.129 27 202 198 155 451 93 3 0 0 0 0 0
Totale 13.798